Global Therapeutic Vaccines Market Size, Forecast 2023-2028

·

3 min read

The latest research study "Therapeutic Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" by IMARC Group, finds that The global therapeutic vaccines market size reached US$ 28.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 51.4 Billion by 2028, exhibiting a growth rate (CAGR) of 10.4% during 2023-2028.

What is Therapeutic Vaccines Market?

Therapeutic vaccines refer to biological medications developed to stimulate or trigger the adaptive immune system to prevent disease-causing infections and organisms. They can be modified based on various applications and needs for treating several disorders, such as human immunodeficiency virus (HIV) infections, cancer, and Alzheimer's. Therapeutic vaccines are available in autoimmune, cancer, infectious, and neurological disease types. They aid in recognizing viruses or cancerous cells, designing antibodies for protecting the body against pathogens, reducing the viral set point in infected patients, and providing adequate clinical outcomes. In addition, therapeutic vaccines are easy to use, cost-effective, and can treat late-stage diseases. As a result, these medications find widespread applications in clinical laboratories, hospitals, and vaccination centers for immunization.

Request a free sample brochure: imarcgroup.com/therapeutic-vaccines-market/..

Therapeutic Vaccines Market Trends and Drivers:

The escalating prevalence of various chronic ailments and the rising need for effective biologic medications for specific and targeted responses are among the primary factors driving the therapeutic vaccines market. Besides this, the launch of several policies by the government bodies to promote compulsory immunization of individuals, owing to the sudden outbreak of the COVID-19 pandemic, and the increasing investments in biopharmaceutical companies to develop viral recombinants are further augmenting the market growth.

Moreover, the growing popularity of morphogenesis gene therapy with exosome-mediated delivery technology for the introduction of patient-specific vaccines to deal with varying cancer types is also catalyzing the global market. Apart from this, the elevating requirement for genetic engineering, the availability of quick deployment vaccines, and the inflating demand for faster medicine-making solutions to improve treatment designs are acting as significant growth-inducing factors. Furthermore, the expanding healthcare sector, fueling consumer awareness toward the accessibility of several restorative medications, and the extensive research and development (R&D) activities to enhance product effectiveness are anticipated to propel the therapeutic vaccines market over the forecasted period.

Therapeutic Vaccines Market Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Type:

  • Antigen Vaccines

  • Dendritic Cell Vaccine

  • DNA Vaccine

  • Tumor Cell Vaccines

Breakup by Disease Type:

  • Autoimmune Disease Vaccines

  • Addiction Vaccine

  • Neurological Disease Vaccine

  • Infectious Disease Vaccine

  • Others

Breakup by Technology:

  • Autologous Vaccines

  • Allogeneic Vaccine

Breakup by Distribution Channel:

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

Click here to view detailed information with table of content: imarcgroup.com/therapeutic-vaccines-market

By Geography:

  • North America: (United States, Canada)

  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)

  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

  • Latin America: (Brazil, Mexico, Others)

  • Middle East and Africa

List of Major Key Players:

The major players in the market are

Agenus Inc., Argos Therapeutics Inc., Bavarian Nordic A/S, Cel-Sci Corporation, CSL Limited, Emergent Biosolutions Inc., GSK plc, Merck & Co. Inc., Pfizer Inc. and Sanofi S.A.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800